Biotechnology Stocks I Performance Guide: Denali Therapeutics Inc. (DNLI)
DNLI has no dividends.
Table and Chart of DNLI Performance
See what a $1,000 investment in DNLI is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| DNLI Returns | |
|---|---|
| Start Date | Jan-31-2018 |
| Start Price | $23.26 |
| End Date | Oct-11-2024 |
| End Price | $28.00 |
| # Prices | 82 |
| Min Date | Jul-31-2018 |
| Min Price | $12.59 |
| Max Date | Dec-31-2020 |
| Max Price | $83.76 |
| Total Return | 20.38% |
| Annualized Return | 2.75% |
| Current Value of $1,000 Purchase | $1,204 |
| Number Returns | 3,321 |
| Average Return | 31.04% |
| Number Profitable Returns | 1,863 |
| Percent Profitable Returns | 56.10% |
| Number Unprofitable Returns | 1,458 |
| Percent Unprofitable Returns | 43.90% |
| Profitable to Unprofitable Returns Ratio | 1.28 |
| DNLI Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -8.660 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -494614016 |
| PE to Growth Ratio | None |
| Price to Book | 3163.87 |
| PRICE DATA | |
| 52 Week High | $1.378 |
| 52 Week Low | $32.13 |
| Analyst Target Price | $-1 |
| 50-Day Moving Average | $14.56 |
| 200-Day Moving Average | $26.19 |
| FINANCIAL DATA | |
| Revenue per Share | $-2.86 |
| Revenue | $0 |
| Profit Margin | 0.9% |
| Return on Equity | -22% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
DNLI Compare Returns with S&P 500
DNLI Trendline Chart
DNLI Moving Average Chart
DNLI Stock Return Map - See Patterns of Gains and Losses
DNLI Stock Returns/Purchase Dates